These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20091252)

  • 21. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation.
    Russo V; Papa AA; Rago A; Ciardiello C; Martino AM; Stazi A; Golino P; Calò L; Nigro G
    Europace; 2022 Jul; 24(7):1148-1155. PubMed ID: 35861549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy.
    Gatzoulis KA; Georgopoulos S; Antoniou CK; Anastasakis A; Dilaveris P; Arsenos P; Sideris S; Tsiachris D; Archontakis S; Sotiropoulos E; Theopistou A; Skiadas I; Kallikazaros I; Stefanadis C; Tousoulis D
    Int J Cardiol; 2018 Mar; 254():175-181. PubMed ID: 29407088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE-EF study.
    Trachanas K; Sideris S; Arsenos P; Tsiachris D; Antoniou CK; Dilaveris P; Triantafyllou K; Xenogiannis I; Tsimos K; Efremidis M; Kanoupakis E; Flevari P; Vassilikos V; Sideris A; Korantzopoulos P; Tousoulis D; Tsioufis K; Gatzoulis K
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12908. PubMed ID: 34873786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
    Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
    Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac Death.
    Sakhi R; Huurman R; Theuns DAMJ; Schinkel AFL; Assaf A; Szili-Torok T; Roos-Hesselink JW; Michels M; Yap SC
    Cardiology; 2021; 146(2):207-212. PubMed ID: 33477163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the Outcome of Ventricular Tachycardia Ablation: Timing and Value of Programmed Ventricular Stimulation.
    Oloriz T; Baratto F; Trevisi N; Barbaro M; Bisceglia C; D'Angelo G; Yamase M; Paglino G; Radinovic A; Della Bella P
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005602. PubMed ID: 29545359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.
    Waks JW; Buxton AE
    Annu Rev Med; 2018 Jan; 69():147-164. PubMed ID: 29414264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
    De Ferrari GM; Rordorf R; Frattini F; Petracci B; De Filippo P; Landolina M
    Europace; 2007 Dec; 9(12):1151-7. PubMed ID: 17947251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Wessler BS; Mooney PJ; Fatima A; Patel P; Koethe BC; Romashko M; Link MS; Maron BJ
    JAMA Cardiol; 2019 Jul; 4(7):644-657. PubMed ID: 31116360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
    Silka MJ; Kron J; Dunnigan A; Dick M
    Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive imaging markers associated with sudden cardiac death.
    van der Bijl P; Delgado V; Bax JJ
    Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Gatzoulis KA; Tsiachris D; Arsenos P; Antoniou CK; Dilaveris P; Sideris S; Kanoupakis E; Simantirakis E; Korantzopoulos P; Goudevenos I; Flevari P; Iliodromitis E; Sideris A; Vassilikos V; Fragakis N; Trachanas K; Vernardos M; Konstantinou I; Tsimos K; Xenogiannis I; Vlachos K; Saplaouras A; Triantafyllou K; Kallikazaros I; Tousoulis D
    Eur Heart J; 2019 Sep; 40(35):2940-2949. PubMed ID: 31049557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias: from risk assessment for sudden cardiac death to therapeutic intervention.
    Wissner E; Kuck KH
    Herz; 2009 Nov; 34(7):503-4. PubMed ID: 20091249
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is an electrophysiological study always necessary before defibrillator implantation?].
    Bänsch D; Antz M
    Herz; 2005 Mar; 30(2):119-22. PubMed ID: 15875100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.